| The Retina Group Of Washington, Pllc | |
|
7501greenway Center Dr, # 300, Greenbelt, MD 20770-3502 | |
| (301) 474-4679 | |
| (301) 474-7182 |
| Full Name | The Retina Group Of Washington, Pllc |
|---|---|
| Type | Facility |
| Speciality | Ophthalmology |
| Location | 7501greenway Center Dr, Greenbelt, Maryland |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225001654 | NPI | - | NPPES |
| Provider Name | Thomas H Yau |
|---|---|
| Provider Type | Practitioner - Ophthalmology |
| Provider Identifiers | NPI Number: 1275626749 PECOS PAC ID: 4789579301 Enrollment ID: I20040223000536 |
News Archive
The first indwelling endoluminal ureteral stent was described over 30 years ago and has since become a routine and indispensable urologic tool. However, the side effects and patient morbidity associated with ureteral stents are not insignificant.
Baylor Research Institute (BRI), the research arm of Baylor Health Care System, announced that it has formed a three-year partnership with Roche to jointly develop programs emerging from the human immunology platforms developed at the Baylor Institute for Immunology Research (BIIR), a component of BRI.
Bruker Corporation today announced that it has acquired Prairie Technologies, Inc. (Prairie), a provider of life science fluorescence microscopy products. The acquisition strengthens Bruker's position in life science markets, adding to the Bruker Nano Surfaces Division's existing life science atomic force microscopy (Bio-AFM) systems.
Synergy Pharmaceuticals, Inc., a developer of new drugs to treat gastrointestinal (GI) disorders and diseases, today announced initiation of dosing of patients in a major Phase II/III clinical trial of plecanatide to treat chronic idiopathic constipation.
MaxMuscleMass.com, an online body building supplement store, wants you to save up to 40% off the retail prices found in gyms and body building supplement retail stores.
› Verified 7 days ago
| Provider Name | Emily A Morin |
|---|---|
| Provider Type | Practitioner - Ophthalmology |
| Provider Identifiers | NPI Number: 1588704985 PECOS PAC ID: 8224020029 Enrollment ID: I20040401000367 |
News Archive
The first indwelling endoluminal ureteral stent was described over 30 years ago and has since become a routine and indispensable urologic tool. However, the side effects and patient morbidity associated with ureteral stents are not insignificant.
Baylor Research Institute (BRI), the research arm of Baylor Health Care System, announced that it has formed a three-year partnership with Roche to jointly develop programs emerging from the human immunology platforms developed at the Baylor Institute for Immunology Research (BIIR), a component of BRI.
Bruker Corporation today announced that it has acquired Prairie Technologies, Inc. (Prairie), a provider of life science fluorescence microscopy products. The acquisition strengthens Bruker's position in life science markets, adding to the Bruker Nano Surfaces Division's existing life science atomic force microscopy (Bio-AFM) systems.
Synergy Pharmaceuticals, Inc., a developer of new drugs to treat gastrointestinal (GI) disorders and diseases, today announced initiation of dosing of patients in a major Phase II/III clinical trial of plecanatide to treat chronic idiopathic constipation.
MaxMuscleMass.com, an online body building supplement store, wants you to save up to 40% off the retail prices found in gyms and body building supplement retail stores.
› Verified 7 days ago
| Provider Name | John D Mitchell |
|---|---|
| Provider Type | Practitioner - Ophthalmology |
| Provider Identifiers | NPI Number: 1952442253 PECOS PAC ID: 4486643251 Enrollment ID: I20040507000422 |
News Archive
The first indwelling endoluminal ureteral stent was described over 30 years ago and has since become a routine and indispensable urologic tool. However, the side effects and patient morbidity associated with ureteral stents are not insignificant.
Baylor Research Institute (BRI), the research arm of Baylor Health Care System, announced that it has formed a three-year partnership with Roche to jointly develop programs emerging from the human immunology platforms developed at the Baylor Institute for Immunology Research (BIIR), a component of BRI.
Bruker Corporation today announced that it has acquired Prairie Technologies, Inc. (Prairie), a provider of life science fluorescence microscopy products. The acquisition strengthens Bruker's position in life science markets, adding to the Bruker Nano Surfaces Division's existing life science atomic force microscopy (Bio-AFM) systems.
Synergy Pharmaceuticals, Inc., a developer of new drugs to treat gastrointestinal (GI) disorders and diseases, today announced initiation of dosing of patients in a major Phase II/III clinical trial of plecanatide to treat chronic idiopathic constipation.
MaxMuscleMass.com, an online body building supplement store, wants you to save up to 40% off the retail prices found in gyms and body building supplement retail stores.
› Verified 7 days ago
| Provider Name | Anna Park |
|---|---|
| Provider Type | Practitioner - Ophthalmology |
| Provider Identifiers | NPI Number: 1295730521 PECOS PAC ID: 3375532864 Enrollment ID: I20040510001078 |
News Archive
The first indwelling endoluminal ureteral stent was described over 30 years ago and has since become a routine and indispensable urologic tool. However, the side effects and patient morbidity associated with ureteral stents are not insignificant.
Baylor Research Institute (BRI), the research arm of Baylor Health Care System, announced that it has formed a three-year partnership with Roche to jointly develop programs emerging from the human immunology platforms developed at the Baylor Institute for Immunology Research (BIIR), a component of BRI.
Bruker Corporation today announced that it has acquired Prairie Technologies, Inc. (Prairie), a provider of life science fluorescence microscopy products. The acquisition strengthens Bruker's position in life science markets, adding to the Bruker Nano Surfaces Division's existing life science atomic force microscopy (Bio-AFM) systems.
Synergy Pharmaceuticals, Inc., a developer of new drugs to treat gastrointestinal (GI) disorders and diseases, today announced initiation of dosing of patients in a major Phase II/III clinical trial of plecanatide to treat chronic idiopathic constipation.
MaxMuscleMass.com, an online body building supplement store, wants you to save up to 40% off the retail prices found in gyms and body building supplement retail stores.
› Verified 7 days ago
| Provider Name | Reshma C Katira |
|---|---|
| Provider Type | Practitioner - Ophthalmology |
| Provider Identifiers | NPI Number: 1700851607 PECOS PAC ID: 0840267522 Enrollment ID: I20040913000792 |
News Archive
The first indwelling endoluminal ureteral stent was described over 30 years ago and has since become a routine and indispensable urologic tool. However, the side effects and patient morbidity associated with ureteral stents are not insignificant.
Baylor Research Institute (BRI), the research arm of Baylor Health Care System, announced that it has formed a three-year partnership with Roche to jointly develop programs emerging from the human immunology platforms developed at the Baylor Institute for Immunology Research (BIIR), a component of BRI.
Bruker Corporation today announced that it has acquired Prairie Technologies, Inc. (Prairie), a provider of life science fluorescence microscopy products. The acquisition strengthens Bruker's position in life science markets, adding to the Bruker Nano Surfaces Division's existing life science atomic force microscopy (Bio-AFM) systems.
Synergy Pharmaceuticals, Inc., a developer of new drugs to treat gastrointestinal (GI) disorders and diseases, today announced initiation of dosing of patients in a major Phase II/III clinical trial of plecanatide to treat chronic idiopathic constipation.
MaxMuscleMass.com, an online body building supplement store, wants you to save up to 40% off the retail prices found in gyms and body building supplement retail stores.
› Verified 7 days ago
| Provider Name | Holly M Gross |
|---|---|
| Provider Type | Practitioner - Ophthalmology |
| Provider Identifiers | NPI Number: 1164498598 PECOS PAC ID: 2668482696 Enrollment ID: I20070212000393 |
News Archive
The first indwelling endoluminal ureteral stent was described over 30 years ago and has since become a routine and indispensable urologic tool. However, the side effects and patient morbidity associated with ureteral stents are not insignificant.
Baylor Research Institute (BRI), the research arm of Baylor Health Care System, announced that it has formed a three-year partnership with Roche to jointly develop programs emerging from the human immunology platforms developed at the Baylor Institute for Immunology Research (BIIR), a component of BRI.
Bruker Corporation today announced that it has acquired Prairie Technologies, Inc. (Prairie), a provider of life science fluorescence microscopy products. The acquisition strengthens Bruker's position in life science markets, adding to the Bruker Nano Surfaces Division's existing life science atomic force microscopy (Bio-AFM) systems.
Synergy Pharmaceuticals, Inc., a developer of new drugs to treat gastrointestinal (GI) disorders and diseases, today announced initiation of dosing of patients in a major Phase II/III clinical trial of plecanatide to treat chronic idiopathic constipation.
MaxMuscleMass.com, an online body building supplement store, wants you to save up to 40% off the retail prices found in gyms and body building supplement retail stores.
› Verified 7 days ago
| Provider Name | Thomas Mark Johnson |
|---|---|
| Provider Type | Practitioner - Ophthalmology |
| Provider Identifiers | NPI Number: 1366498545 PECOS PAC ID: 9739081969 Enrollment ID: I20070503000432 |
News Archive
The first indwelling endoluminal ureteral stent was described over 30 years ago and has since become a routine and indispensable urologic tool. However, the side effects and patient morbidity associated with ureteral stents are not insignificant.
Baylor Research Institute (BRI), the research arm of Baylor Health Care System, announced that it has formed a three-year partnership with Roche to jointly develop programs emerging from the human immunology platforms developed at the Baylor Institute for Immunology Research (BIIR), a component of BRI.
Bruker Corporation today announced that it has acquired Prairie Technologies, Inc. (Prairie), a provider of life science fluorescence microscopy products. The acquisition strengthens Bruker's position in life science markets, adding to the Bruker Nano Surfaces Division's existing life science atomic force microscopy (Bio-AFM) systems.
Synergy Pharmaceuticals, Inc., a developer of new drugs to treat gastrointestinal (GI) disorders and diseases, today announced initiation of dosing of patients in a major Phase II/III clinical trial of plecanatide to treat chronic idiopathic constipation.
MaxMuscleMass.com, an online body building supplement store, wants you to save up to 40% off the retail prices found in gyms and body building supplement retail stores.
› Verified 7 days ago
| Provider Name | Michael Min Shyue Lai |
|---|---|
| Provider Type | Practitioner - Ophthalmology |
| Provider Identifiers | NPI Number: 1962432260 PECOS PAC ID: 5092752162 Enrollment ID: I20070925000672 |
News Archive
The first indwelling endoluminal ureteral stent was described over 30 years ago and has since become a routine and indispensable urologic tool. However, the side effects and patient morbidity associated with ureteral stents are not insignificant.
Baylor Research Institute (BRI), the research arm of Baylor Health Care System, announced that it has formed a three-year partnership with Roche to jointly develop programs emerging from the human immunology platforms developed at the Baylor Institute for Immunology Research (BIIR), a component of BRI.
Bruker Corporation today announced that it has acquired Prairie Technologies, Inc. (Prairie), a provider of life science fluorescence microscopy products. The acquisition strengthens Bruker's position in life science markets, adding to the Bruker Nano Surfaces Division's existing life science atomic force microscopy (Bio-AFM) systems.
Synergy Pharmaceuticals, Inc., a developer of new drugs to treat gastrointestinal (GI) disorders and diseases, today announced initiation of dosing of patients in a major Phase II/III clinical trial of plecanatide to treat chronic idiopathic constipation.
MaxMuscleMass.com, an online body building supplement store, wants you to save up to 40% off the retail prices found in gyms and body building supplement retail stores.
› Verified 7 days ago
| Provider Name | Alexander Melamud |
|---|---|
| Provider Type | Practitioner - Ophthalmology |
| Provider Identifiers | NPI Number: 1669573788 PECOS PAC ID: 3779516018 Enrollment ID: I20080130000407 |
News Archive
The first indwelling endoluminal ureteral stent was described over 30 years ago and has since become a routine and indispensable urologic tool. However, the side effects and patient morbidity associated with ureteral stents are not insignificant.
Baylor Research Institute (BRI), the research arm of Baylor Health Care System, announced that it has formed a three-year partnership with Roche to jointly develop programs emerging from the human immunology platforms developed at the Baylor Institute for Immunology Research (BIIR), a component of BRI.
Bruker Corporation today announced that it has acquired Prairie Technologies, Inc. (Prairie), a provider of life science fluorescence microscopy products. The acquisition strengthens Bruker's position in life science markets, adding to the Bruker Nano Surfaces Division's existing life science atomic force microscopy (Bio-AFM) systems.
Synergy Pharmaceuticals, Inc., a developer of new drugs to treat gastrointestinal (GI) disorders and diseases, today announced initiation of dosing of patients in a major Phase II/III clinical trial of plecanatide to treat chronic idiopathic constipation.
MaxMuscleMass.com, an online body building supplement store, wants you to save up to 40% off the retail prices found in gyms and body building supplement retail stores.
› Verified 7 days ago
| Provider Name | David M Wanicur |
|---|---|
| Provider Type | Practitioner - Ophthalmology |
| Provider Identifiers | NPI Number: 1598837742 PECOS PAC ID: 4789769860 Enrollment ID: I20080313000425 |
News Archive
The first indwelling endoluminal ureteral stent was described over 30 years ago and has since become a routine and indispensable urologic tool. However, the side effects and patient morbidity associated with ureteral stents are not insignificant.
Baylor Research Institute (BRI), the research arm of Baylor Health Care System, announced that it has formed a three-year partnership with Roche to jointly develop programs emerging from the human immunology platforms developed at the Baylor Institute for Immunology Research (BIIR), a component of BRI.
Bruker Corporation today announced that it has acquired Prairie Technologies, Inc. (Prairie), a provider of life science fluorescence microscopy products. The acquisition strengthens Bruker's position in life science markets, adding to the Bruker Nano Surfaces Division's existing life science atomic force microscopy (Bio-AFM) systems.
Synergy Pharmaceuticals, Inc., a developer of new drugs to treat gastrointestinal (GI) disorders and diseases, today announced initiation of dosing of patients in a major Phase II/III clinical trial of plecanatide to treat chronic idiopathic constipation.
MaxMuscleMass.com, an online body building supplement store, wants you to save up to 40% off the retail prices found in gyms and body building supplement retail stores.
› Verified 7 days ago
| Provider Name | Reginald J. Sanders |
|---|---|
| Provider Type | Practitioner - Ophthalmology |
| Provider Identifiers | NPI Number: 1922072198 PECOS PAC ID: 2062505647 Enrollment ID: I20080514000495 |
News Archive
The first indwelling endoluminal ureteral stent was described over 30 years ago and has since become a routine and indispensable urologic tool. However, the side effects and patient morbidity associated with ureteral stents are not insignificant.
Baylor Research Institute (BRI), the research arm of Baylor Health Care System, announced that it has formed a three-year partnership with Roche to jointly develop programs emerging from the human immunology platforms developed at the Baylor Institute for Immunology Research (BIIR), a component of BRI.
Bruker Corporation today announced that it has acquired Prairie Technologies, Inc. (Prairie), a provider of life science fluorescence microscopy products. The acquisition strengthens Bruker's position in life science markets, adding to the Bruker Nano Surfaces Division's existing life science atomic force microscopy (Bio-AFM) systems.
Synergy Pharmaceuticals, Inc., a developer of new drugs to treat gastrointestinal (GI) disorders and diseases, today announced initiation of dosing of patients in a major Phase II/III clinical trial of plecanatide to treat chronic idiopathic constipation.
MaxMuscleMass.com, an online body building supplement store, wants you to save up to 40% off the retail prices found in gyms and body building supplement retail stores.
› Verified 7 days ago
| Provider Name | Mark J Schefkind |
|---|---|
| Provider Type | Practitioner - Ophthalmology |
| Provider Identifiers | NPI Number: 1972500650 PECOS PAC ID: 4486716990 Enrollment ID: I20081217000535 |
News Archive
The first indwelling endoluminal ureteral stent was described over 30 years ago and has since become a routine and indispensable urologic tool. However, the side effects and patient morbidity associated with ureteral stents are not insignificant.
Baylor Research Institute (BRI), the research arm of Baylor Health Care System, announced that it has formed a three-year partnership with Roche to jointly develop programs emerging from the human immunology platforms developed at the Baylor Institute for Immunology Research (BIIR), a component of BRI.
Bruker Corporation today announced that it has acquired Prairie Technologies, Inc. (Prairie), a provider of life science fluorescence microscopy products. The acquisition strengthens Bruker's position in life science markets, adding to the Bruker Nano Surfaces Division's existing life science atomic force microscopy (Bio-AFM) systems.
Synergy Pharmaceuticals, Inc., a developer of new drugs to treat gastrointestinal (GI) disorders and diseases, today announced initiation of dosing of patients in a major Phase II/III clinical trial of plecanatide to treat chronic idiopathic constipation.
MaxMuscleMass.com, an online body building supplement store, wants you to save up to 40% off the retail prices found in gyms and body building supplement retail stores.
› Verified 7 days ago
| Provider Name | John R Minarcik |
|---|---|
| Provider Type | Practitioner - Ophthalmology |
| Provider Identifiers | NPI Number: 1750427555 PECOS PAC ID: 3375694482 Enrollment ID: I20090701000420 |
News Archive
The first indwelling endoluminal ureteral stent was described over 30 years ago and has since become a routine and indispensable urologic tool. However, the side effects and patient morbidity associated with ureteral stents are not insignificant.
Baylor Research Institute (BRI), the research arm of Baylor Health Care System, announced that it has formed a three-year partnership with Roche to jointly develop programs emerging from the human immunology platforms developed at the Baylor Institute for Immunology Research (BIIR), a component of BRI.
Bruker Corporation today announced that it has acquired Prairie Technologies, Inc. (Prairie), a provider of life science fluorescence microscopy products. The acquisition strengthens Bruker's position in life science markets, adding to the Bruker Nano Surfaces Division's existing life science atomic force microscopy (Bio-AFM) systems.
Synergy Pharmaceuticals, Inc., a developer of new drugs to treat gastrointestinal (GI) disorders and diseases, today announced initiation of dosing of patients in a major Phase II/III clinical trial of plecanatide to treat chronic idiopathic constipation.
MaxMuscleMass.com, an online body building supplement store, wants you to save up to 40% off the retail prices found in gyms and body building supplement retail stores.
› Verified 7 days ago
| Provider Name | Eric David Weichel |
|---|---|
| Provider Type | Practitioner - Ophthalmology |
| Provider Identifiers | NPI Number: 1124053350 PECOS PAC ID: 2163317199 Enrollment ID: I20090730000474 |
News Archive
The first indwelling endoluminal ureteral stent was described over 30 years ago and has since become a routine and indispensable urologic tool. However, the side effects and patient morbidity associated with ureteral stents are not insignificant.
Baylor Research Institute (BRI), the research arm of Baylor Health Care System, announced that it has formed a three-year partnership with Roche to jointly develop programs emerging from the human immunology platforms developed at the Baylor Institute for Immunology Research (BIIR), a component of BRI.
Bruker Corporation today announced that it has acquired Prairie Technologies, Inc. (Prairie), a provider of life science fluorescence microscopy products. The acquisition strengthens Bruker's position in life science markets, adding to the Bruker Nano Surfaces Division's existing life science atomic force microscopy (Bio-AFM) systems.
Synergy Pharmaceuticals, Inc., a developer of new drugs to treat gastrointestinal (GI) disorders and diseases, today announced initiation of dosing of patients in a major Phase II/III clinical trial of plecanatide to treat chronic idiopathic constipation.
MaxMuscleMass.com, an online body building supplement store, wants you to save up to 40% off the retail prices found in gyms and body building supplement retail stores.
› Verified 7 days ago
| Provider Name | Stacy J Bang |
|---|---|
| Provider Type | Practitioner - Ophthalmology |
| Provider Identifiers | NPI Number: 1053589499 PECOS PAC ID: 3476627035 Enrollment ID: I20090814000262 |
News Archive
The first indwelling endoluminal ureteral stent was described over 30 years ago and has since become a routine and indispensable urologic tool. However, the side effects and patient morbidity associated with ureteral stents are not insignificant.
Baylor Research Institute (BRI), the research arm of Baylor Health Care System, announced that it has formed a three-year partnership with Roche to jointly develop programs emerging from the human immunology platforms developed at the Baylor Institute for Immunology Research (BIIR), a component of BRI.
Bruker Corporation today announced that it has acquired Prairie Technologies, Inc. (Prairie), a provider of life science fluorescence microscopy products. The acquisition strengthens Bruker's position in life science markets, adding to the Bruker Nano Surfaces Division's existing life science atomic force microscopy (Bio-AFM) systems.
Synergy Pharmaceuticals, Inc., a developer of new drugs to treat gastrointestinal (GI) disorders and diseases, today announced initiation of dosing of patients in a major Phase II/III clinical trial of plecanatide to treat chronic idiopathic constipation.
MaxMuscleMass.com, an online body building supplement store, wants you to save up to 40% off the retail prices found in gyms and body building supplement retail stores.
› Verified 7 days ago
| Provider Name | Eric Sean Lee |
|---|---|
| Provider Type | Practitioner - Ophthalmology |
| Provider Identifiers | NPI Number: 1356329981 PECOS PAC ID: 6507865029 Enrollment ID: I20091117000535 |
News Archive
The first indwelling endoluminal ureteral stent was described over 30 years ago and has since become a routine and indispensable urologic tool. However, the side effects and patient morbidity associated with ureteral stents are not insignificant.
Baylor Research Institute (BRI), the research arm of Baylor Health Care System, announced that it has formed a three-year partnership with Roche to jointly develop programs emerging from the human immunology platforms developed at the Baylor Institute for Immunology Research (BIIR), a component of BRI.
Bruker Corporation today announced that it has acquired Prairie Technologies, Inc. (Prairie), a provider of life science fluorescence microscopy products. The acquisition strengthens Bruker's position in life science markets, adding to the Bruker Nano Surfaces Division's existing life science atomic force microscopy (Bio-AFM) systems.
Synergy Pharmaceuticals, Inc., a developer of new drugs to treat gastrointestinal (GI) disorders and diseases, today announced initiation of dosing of patients in a major Phase II/III clinical trial of plecanatide to treat chronic idiopathic constipation.
MaxMuscleMass.com, an online body building supplement store, wants you to save up to 40% off the retail prices found in gyms and body building supplement retail stores.
› Verified 7 days ago
| Provider Name | Daniel Berinstein |
|---|---|
| Provider Type | Practitioner - Ophthalmology |
| Provider Identifiers | NPI Number: 1366416406 PECOS PAC ID: 9032202619 Enrollment ID: I20100107000227 |
News Archive
The first indwelling endoluminal ureteral stent was described over 30 years ago and has since become a routine and indispensable urologic tool. However, the side effects and patient morbidity associated with ureteral stents are not insignificant.
Baylor Research Institute (BRI), the research arm of Baylor Health Care System, announced that it has formed a three-year partnership with Roche to jointly develop programs emerging from the human immunology platforms developed at the Baylor Institute for Immunology Research (BIIR), a component of BRI.
Bruker Corporation today announced that it has acquired Prairie Technologies, Inc. (Prairie), a provider of life science fluorescence microscopy products. The acquisition strengthens Bruker's position in life science markets, adding to the Bruker Nano Surfaces Division's existing life science atomic force microscopy (Bio-AFM) systems.
Synergy Pharmaceuticals, Inc., a developer of new drugs to treat gastrointestinal (GI) disorders and diseases, today announced initiation of dosing of patients in a major Phase II/III clinical trial of plecanatide to treat chronic idiopathic constipation.
MaxMuscleMass.com, an online body building supplement store, wants you to save up to 40% off the retail prices found in gyms and body building supplement retail stores.
› Verified 7 days ago
| Provider Name | Richard Garfinkel |
|---|---|
| Provider Type | Practitioner - Ophthalmology |
| Provider Identifiers | NPI Number: 1831163997 PECOS PAC ID: 2961595541 Enrollment ID: I20100108000538 |
News Archive
The first indwelling endoluminal ureteral stent was described over 30 years ago and has since become a routine and indispensable urologic tool. However, the side effects and patient morbidity associated with ureteral stents are not insignificant.
Baylor Research Institute (BRI), the research arm of Baylor Health Care System, announced that it has formed a three-year partnership with Roche to jointly develop programs emerging from the human immunology platforms developed at the Baylor Institute for Immunology Research (BIIR), a component of BRI.
Bruker Corporation today announced that it has acquired Prairie Technologies, Inc. (Prairie), a provider of life science fluorescence microscopy products. The acquisition strengthens Bruker's position in life science markets, adding to the Bruker Nano Surfaces Division's existing life science atomic force microscopy (Bio-AFM) systems.
Synergy Pharmaceuticals, Inc., a developer of new drugs to treat gastrointestinal (GI) disorders and diseases, today announced initiation of dosing of patients in a major Phase II/III clinical trial of plecanatide to treat chronic idiopathic constipation.
MaxMuscleMass.com, an online body building supplement store, wants you to save up to 40% off the retail prices found in gyms and body building supplement retail stores.
› Verified 7 days ago
| Provider Name | Geoffrey Kaplan |
|---|---|
| Provider Type | Practitioner - Ophthalmology |
| Provider Identifiers | NPI Number: 1174597140 PECOS PAC ID: 6507959186 Enrollment ID: I20100112000459 |
News Archive
The first indwelling endoluminal ureteral stent was described over 30 years ago and has since become a routine and indispensable urologic tool. However, the side effects and patient morbidity associated with ureteral stents are not insignificant.
Baylor Research Institute (BRI), the research arm of Baylor Health Care System, announced that it has formed a three-year partnership with Roche to jointly develop programs emerging from the human immunology platforms developed at the Baylor Institute for Immunology Research (BIIR), a component of BRI.
Bruker Corporation today announced that it has acquired Prairie Technologies, Inc. (Prairie), a provider of life science fluorescence microscopy products. The acquisition strengthens Bruker's position in life science markets, adding to the Bruker Nano Surfaces Division's existing life science atomic force microscopy (Bio-AFM) systems.
Synergy Pharmaceuticals, Inc., a developer of new drugs to treat gastrointestinal (GI) disorders and diseases, today announced initiation of dosing of patients in a major Phase II/III clinical trial of plecanatide to treat chronic idiopathic constipation.
MaxMuscleMass.com, an online body building supplement store, wants you to save up to 40% off the retail prices found in gyms and body building supplement retail stores.
› Verified 7 days ago
| Provider Name | William Phillips Ii |
|---|---|
| Provider Type | Practitioner - Ophthalmology |
| Provider Identifiers | NPI Number: 1518931765 PECOS PAC ID: 5496848079 Enrollment ID: I20100115000829 |
News Archive
The first indwelling endoluminal ureteral stent was described over 30 years ago and has since become a routine and indispensable urologic tool. However, the side effects and patient morbidity associated with ureteral stents are not insignificant.
Baylor Research Institute (BRI), the research arm of Baylor Health Care System, announced that it has formed a three-year partnership with Roche to jointly develop programs emerging from the human immunology platforms developed at the Baylor Institute for Immunology Research (BIIR), a component of BRI.
Bruker Corporation today announced that it has acquired Prairie Technologies, Inc. (Prairie), a provider of life science fluorescence microscopy products. The acquisition strengthens Bruker's position in life science markets, adding to the Bruker Nano Surfaces Division's existing life science atomic force microscopy (Bio-AFM) systems.
Synergy Pharmaceuticals, Inc., a developer of new drugs to treat gastrointestinal (GI) disorders and diseases, today announced initiation of dosing of patients in a major Phase II/III clinical trial of plecanatide to treat chronic idiopathic constipation.
MaxMuscleMass.com, an online body building supplement store, wants you to save up to 40% off the retail prices found in gyms and body building supplement retail stores.
› Verified 7 days ago
| Provider Name | Vinay Natver Desai |
|---|---|
| Provider Type | Practitioner - Ophthalmology |
| Provider Identifiers | NPI Number: 1881668119 PECOS PAC ID: 9830120799 Enrollment ID: I20100217000407 |
News Archive
The first indwelling endoluminal ureteral stent was described over 30 years ago and has since become a routine and indispensable urologic tool. However, the side effects and patient morbidity associated with ureteral stents are not insignificant.
Baylor Research Institute (BRI), the research arm of Baylor Health Care System, announced that it has formed a three-year partnership with Roche to jointly develop programs emerging from the human immunology platforms developed at the Baylor Institute for Immunology Research (BIIR), a component of BRI.
Bruker Corporation today announced that it has acquired Prairie Technologies, Inc. (Prairie), a provider of life science fluorescence microscopy products. The acquisition strengthens Bruker's position in life science markets, adding to the Bruker Nano Surfaces Division's existing life science atomic force microscopy (Bio-AFM) systems.
Synergy Pharmaceuticals, Inc., a developer of new drugs to treat gastrointestinal (GI) disorders and diseases, today announced initiation of dosing of patients in a major Phase II/III clinical trial of plecanatide to treat chronic idiopathic constipation.
MaxMuscleMass.com, an online body building supplement store, wants you to save up to 40% off the retail prices found in gyms and body building supplement retail stores.
› Verified 7 days ago
| Provider Name | Mohammed Barazi |
|---|---|
| Provider Type | Practitioner - Ophthalmology |
| Provider Identifiers | NPI Number: 1447223888 PECOS PAC ID: 6800865239 Enrollment ID: I20101207000083 |
News Archive
The first indwelling endoluminal ureteral stent was described over 30 years ago and has since become a routine and indispensable urologic tool. However, the side effects and patient morbidity associated with ureteral stents are not insignificant.
Baylor Research Institute (BRI), the research arm of Baylor Health Care System, announced that it has formed a three-year partnership with Roche to jointly develop programs emerging from the human immunology platforms developed at the Baylor Institute for Immunology Research (BIIR), a component of BRI.
Bruker Corporation today announced that it has acquired Prairie Technologies, Inc. (Prairie), a provider of life science fluorescence microscopy products. The acquisition strengthens Bruker's position in life science markets, adding to the Bruker Nano Surfaces Division's existing life science atomic force microscopy (Bio-AFM) systems.
Synergy Pharmaceuticals, Inc., a developer of new drugs to treat gastrointestinal (GI) disorders and diseases, today announced initiation of dosing of patients in a major Phase II/III clinical trial of plecanatide to treat chronic idiopathic constipation.
MaxMuscleMass.com, an online body building supplement store, wants you to save up to 40% off the retail prices found in gyms and body building supplement retail stores.
› Verified 7 days ago
| Provider Name | Deborah Ann Reid |
|---|---|
| Provider Type | Practitioner - Ophthalmology |
| Provider Identifiers | NPI Number: 1942243332 PECOS PAC ID: 2961682422 Enrollment ID: I20110216000028 |
News Archive
The first indwelling endoluminal ureteral stent was described over 30 years ago and has since become a routine and indispensable urologic tool. However, the side effects and patient morbidity associated with ureteral stents are not insignificant.
Baylor Research Institute (BRI), the research arm of Baylor Health Care System, announced that it has formed a three-year partnership with Roche to jointly develop programs emerging from the human immunology platforms developed at the Baylor Institute for Immunology Research (BIIR), a component of BRI.
Bruker Corporation today announced that it has acquired Prairie Technologies, Inc. (Prairie), a provider of life science fluorescence microscopy products. The acquisition strengthens Bruker's position in life science markets, adding to the Bruker Nano Surfaces Division's existing life science atomic force microscopy (Bio-AFM) systems.
Synergy Pharmaceuticals, Inc., a developer of new drugs to treat gastrointestinal (GI) disorders and diseases, today announced initiation of dosing of patients in a major Phase II/III clinical trial of plecanatide to treat chronic idiopathic constipation.
MaxMuscleMass.com, an online body building supplement store, wants you to save up to 40% off the retail prices found in gyms and body building supplement retail stores.
› Verified 7 days ago
| Provider Name | Cuong D. Vu |
|---|---|
| Provider Type | Practitioner - Ophthalmology |
| Provider Identifiers | NPI Number: 1205878378 PECOS PAC ID: 7810177383 Enrollment ID: I20110216000114 |
News Archive
The first indwelling endoluminal ureteral stent was described over 30 years ago and has since become a routine and indispensable urologic tool. However, the side effects and patient morbidity associated with ureteral stents are not insignificant.
Baylor Research Institute (BRI), the research arm of Baylor Health Care System, announced that it has formed a three-year partnership with Roche to jointly develop programs emerging from the human immunology platforms developed at the Baylor Institute for Immunology Research (BIIR), a component of BRI.
Bruker Corporation today announced that it has acquired Prairie Technologies, Inc. (Prairie), a provider of life science fluorescence microscopy products. The acquisition strengthens Bruker's position in life science markets, adding to the Bruker Nano Surfaces Division's existing life science atomic force microscopy (Bio-AFM) systems.
Synergy Pharmaceuticals, Inc., a developer of new drugs to treat gastrointestinal (GI) disorders and diseases, today announced initiation of dosing of patients in a major Phase II/III clinical trial of plecanatide to treat chronic idiopathic constipation.
MaxMuscleMass.com, an online body building supplement store, wants you to save up to 40% off the retail prices found in gyms and body building supplement retail stores.
› Verified 7 days ago
| Provider Name | Aziz A Khanifar |
|---|---|
| Provider Type | Practitioner - Ophthalmology |
| Provider Identifiers | NPI Number: 1053327445 PECOS PAC ID: 1850396722 Enrollment ID: I20110304000249 |
News Archive
The first indwelling endoluminal ureteral stent was described over 30 years ago and has since become a routine and indispensable urologic tool. However, the side effects and patient morbidity associated with ureteral stents are not insignificant.
Baylor Research Institute (BRI), the research arm of Baylor Health Care System, announced that it has formed a three-year partnership with Roche to jointly develop programs emerging from the human immunology platforms developed at the Baylor Institute for Immunology Research (BIIR), a component of BRI.
Bruker Corporation today announced that it has acquired Prairie Technologies, Inc. (Prairie), a provider of life science fluorescence microscopy products. The acquisition strengthens Bruker's position in life science markets, adding to the Bruker Nano Surfaces Division's existing life science atomic force microscopy (Bio-AFM) systems.
Synergy Pharmaceuticals, Inc., a developer of new drugs to treat gastrointestinal (GI) disorders and diseases, today announced initiation of dosing of patients in a major Phase II/III clinical trial of plecanatide to treat chronic idiopathic constipation.
MaxMuscleMass.com, an online body building supplement store, wants you to save up to 40% off the retail prices found in gyms and body building supplement retail stores.
› Verified 7 days ago
| Provider Name | Gayatri S Reilly |
|---|---|
| Provider Type | Practitioner - Ophthalmology |
| Provider Identifiers | NPI Number: 1174718456 PECOS PAC ID: 1557547437 Enrollment ID: I20110512000683 |
News Archive
The first indwelling endoluminal ureteral stent was described over 30 years ago and has since become a routine and indispensable urologic tool. However, the side effects and patient morbidity associated with ureteral stents are not insignificant.
Baylor Research Institute (BRI), the research arm of Baylor Health Care System, announced that it has formed a three-year partnership with Roche to jointly develop programs emerging from the human immunology platforms developed at the Baylor Institute for Immunology Research (BIIR), a component of BRI.
Bruker Corporation today announced that it has acquired Prairie Technologies, Inc. (Prairie), a provider of life science fluorescence microscopy products. The acquisition strengthens Bruker's position in life science markets, adding to the Bruker Nano Surfaces Division's existing life science atomic force microscopy (Bio-AFM) systems.
Synergy Pharmaceuticals, Inc., a developer of new drugs to treat gastrointestinal (GI) disorders and diseases, today announced initiation of dosing of patients in a major Phase II/III clinical trial of plecanatide to treat chronic idiopathic constipation.
MaxMuscleMass.com, an online body building supplement store, wants you to save up to 40% off the retail prices found in gyms and body building supplement retail stores.
› Verified 7 days ago
| Provider Name | Gordon Byrnes |
|---|---|
| Provider Type | Practitioner - Ophthalmology |
| Provider Identifiers | NPI Number: 1295709699 PECOS PAC ID: 0547251563 Enrollment ID: I20110617000607 |
News Archive
The first indwelling endoluminal ureteral stent was described over 30 years ago and has since become a routine and indispensable urologic tool. However, the side effects and patient morbidity associated with ureteral stents are not insignificant.
Baylor Research Institute (BRI), the research arm of Baylor Health Care System, announced that it has formed a three-year partnership with Roche to jointly develop programs emerging from the human immunology platforms developed at the Baylor Institute for Immunology Research (BIIR), a component of BRI.
Bruker Corporation today announced that it has acquired Prairie Technologies, Inc. (Prairie), a provider of life science fluorescence microscopy products. The acquisition strengthens Bruker's position in life science markets, adding to the Bruker Nano Surfaces Division's existing life science atomic force microscopy (Bio-AFM) systems.
Synergy Pharmaceuticals, Inc., a developer of new drugs to treat gastrointestinal (GI) disorders and diseases, today announced initiation of dosing of patients in a major Phase II/III clinical trial of plecanatide to treat chronic idiopathic constipation.
MaxMuscleMass.com, an online body building supplement store, wants you to save up to 40% off the retail prices found in gyms and body building supplement retail stores.
› Verified 7 days ago
| Provider Name | Michael H Osman |
|---|---|
| Provider Type | Practitioner - Ophthalmology |
| Provider Identifiers | NPI Number: 1821062803 PECOS PAC ID: 2860585445 Enrollment ID: I20111212000834 |
News Archive
The first indwelling endoluminal ureteral stent was described over 30 years ago and has since become a routine and indispensable urologic tool. However, the side effects and patient morbidity associated with ureteral stents are not insignificant.
Baylor Research Institute (BRI), the research arm of Baylor Health Care System, announced that it has formed a three-year partnership with Roche to jointly develop programs emerging from the human immunology platforms developed at the Baylor Institute for Immunology Research (BIIR), a component of BRI.
Bruker Corporation today announced that it has acquired Prairie Technologies, Inc. (Prairie), a provider of life science fluorescence microscopy products. The acquisition strengthens Bruker's position in life science markets, adding to the Bruker Nano Surfaces Division's existing life science atomic force microscopy (Bio-AFM) systems.
Synergy Pharmaceuticals, Inc., a developer of new drugs to treat gastrointestinal (GI) disorders and diseases, today announced initiation of dosing of patients in a major Phase II/III clinical trial of plecanatide to treat chronic idiopathic constipation.
MaxMuscleMass.com, an online body building supplement store, wants you to save up to 40% off the retail prices found in gyms and body building supplement retail stores.
› Verified 7 days ago
| Provider Name | Arusha Gupta |
|---|---|
| Provider Type | Practitioner - Ophthalmology |
| Provider Identifiers | NPI Number: 1003007816 PECOS PAC ID: 9638201171 Enrollment ID: I20120117000238 |
News Archive
The first indwelling endoluminal ureteral stent was described over 30 years ago and has since become a routine and indispensable urologic tool. However, the side effects and patient morbidity associated with ureteral stents are not insignificant.
Baylor Research Institute (BRI), the research arm of Baylor Health Care System, announced that it has formed a three-year partnership with Roche to jointly develop programs emerging from the human immunology platforms developed at the Baylor Institute for Immunology Research (BIIR), a component of BRI.
Bruker Corporation today announced that it has acquired Prairie Technologies, Inc. (Prairie), a provider of life science fluorescence microscopy products. The acquisition strengthens Bruker's position in life science markets, adding to the Bruker Nano Surfaces Division's existing life science atomic force microscopy (Bio-AFM) systems.
Synergy Pharmaceuticals, Inc., a developer of new drugs to treat gastrointestinal (GI) disorders and diseases, today announced initiation of dosing of patients in a major Phase II/III clinical trial of plecanatide to treat chronic idiopathic constipation.
MaxMuscleMass.com, an online body building supplement store, wants you to save up to 40% off the retail prices found in gyms and body building supplement retail stores.
› Verified 7 days ago
| Provider Name | Dal Chun |
|---|---|
| Provider Type | Practitioner - Ophthalmology |
| Provider Identifiers | NPI Number: 1578587135 PECOS PAC ID: 7214907070 Enrollment ID: I20120430000151 |
News Archive
The first indwelling endoluminal ureteral stent was described over 30 years ago and has since become a routine and indispensable urologic tool. However, the side effects and patient morbidity associated with ureteral stents are not insignificant.
Baylor Research Institute (BRI), the research arm of Baylor Health Care System, announced that it has formed a three-year partnership with Roche to jointly develop programs emerging from the human immunology platforms developed at the Baylor Institute for Immunology Research (BIIR), a component of BRI.
Bruker Corporation today announced that it has acquired Prairie Technologies, Inc. (Prairie), a provider of life science fluorescence microscopy products. The acquisition strengthens Bruker's position in life science markets, adding to the Bruker Nano Surfaces Division's existing life science atomic force microscopy (Bio-AFM) systems.
Synergy Pharmaceuticals, Inc., a developer of new drugs to treat gastrointestinal (GI) disorders and diseases, today announced initiation of dosing of patients in a major Phase II/III clinical trial of plecanatide to treat chronic idiopathic constipation.
MaxMuscleMass.com, an online body building supplement store, wants you to save up to 40% off the retail prices found in gyms and body building supplement retail stores.
› Verified 7 days ago
| Provider Name | Juanita S Bryant |
|---|---|
| Provider Type | Practitioner - Ophthalmology |
| Provider Identifiers | NPI Number: 1235388679 PECOS PAC ID: 6608909270 Enrollment ID: I20120711000396 |
News Archive
The first indwelling endoluminal ureteral stent was described over 30 years ago and has since become a routine and indispensable urologic tool. However, the side effects and patient morbidity associated with ureteral stents are not insignificant.
Baylor Research Institute (BRI), the research arm of Baylor Health Care System, announced that it has formed a three-year partnership with Roche to jointly develop programs emerging from the human immunology platforms developed at the Baylor Institute for Immunology Research (BIIR), a component of BRI.
Bruker Corporation today announced that it has acquired Prairie Technologies, Inc. (Prairie), a provider of life science fluorescence microscopy products. The acquisition strengthens Bruker's position in life science markets, adding to the Bruker Nano Surfaces Division's existing life science atomic force microscopy (Bio-AFM) systems.
Synergy Pharmaceuticals, Inc., a developer of new drugs to treat gastrointestinal (GI) disorders and diseases, today announced initiation of dosing of patients in a major Phase II/III clinical trial of plecanatide to treat chronic idiopathic constipation.
MaxMuscleMass.com, an online body building supplement store, wants you to save up to 40% off the retail prices found in gyms and body building supplement retail stores.
› Verified 7 days ago
| Provider Name | Amy L Nicholas |
|---|---|
| Provider Type | Practitioner - Ophthalmology |
| Provider Identifiers | NPI Number: 1407081680 PECOS PAC ID: 7416199195 Enrollment ID: I20130808000441 |
News Archive
The first indwelling endoluminal ureteral stent was described over 30 years ago and has since become a routine and indispensable urologic tool. However, the side effects and patient morbidity associated with ureteral stents are not insignificant.
Baylor Research Institute (BRI), the research arm of Baylor Health Care System, announced that it has formed a three-year partnership with Roche to jointly develop programs emerging from the human immunology platforms developed at the Baylor Institute for Immunology Research (BIIR), a component of BRI.
Bruker Corporation today announced that it has acquired Prairie Technologies, Inc. (Prairie), a provider of life science fluorescence microscopy products. The acquisition strengthens Bruker's position in life science markets, adding to the Bruker Nano Surfaces Division's existing life science atomic force microscopy (Bio-AFM) systems.
Synergy Pharmaceuticals, Inc., a developer of new drugs to treat gastrointestinal (GI) disorders and diseases, today announced initiation of dosing of patients in a major Phase II/III clinical trial of plecanatide to treat chronic idiopathic constipation.
MaxMuscleMass.com, an online body building supplement store, wants you to save up to 40% off the retail prices found in gyms and body building supplement retail stores.
› Verified 7 days ago
| Provider Name | Jordana G. Fein |
|---|---|
| Provider Type | Practitioner - Ophthalmology |
| Provider Identifiers | NPI Number: 1841463098 PECOS PAC ID: 0446408736 Enrollment ID: I20140930002990 |
News Archive
The first indwelling endoluminal ureteral stent was described over 30 years ago and has since become a routine and indispensable urologic tool. However, the side effects and patient morbidity associated with ureteral stents are not insignificant.
Baylor Research Institute (BRI), the research arm of Baylor Health Care System, announced that it has formed a three-year partnership with Roche to jointly develop programs emerging from the human immunology platforms developed at the Baylor Institute for Immunology Research (BIIR), a component of BRI.
Bruker Corporation today announced that it has acquired Prairie Technologies, Inc. (Prairie), a provider of life science fluorescence microscopy products. The acquisition strengthens Bruker's position in life science markets, adding to the Bruker Nano Surfaces Division's existing life science atomic force microscopy (Bio-AFM) systems.
Synergy Pharmaceuticals, Inc., a developer of new drugs to treat gastrointestinal (GI) disorders and diseases, today announced initiation of dosing of patients in a major Phase II/III clinical trial of plecanatide to treat chronic idiopathic constipation.
MaxMuscleMass.com, an online body building supplement store, wants you to save up to 40% off the retail prices found in gyms and body building supplement retail stores.
› Verified 7 days ago
| Provider Name | Joshua Levinson |
|---|---|
| Provider Type | Practitioner - Ophthalmology |
| Provider Identifiers | NPI Number: 1982960936 PECOS PAC ID: 4082903240 Enrollment ID: I20160512000141 |
News Archive
The first indwelling endoluminal ureteral stent was described over 30 years ago and has since become a routine and indispensable urologic tool. However, the side effects and patient morbidity associated with ureteral stents are not insignificant.
Baylor Research Institute (BRI), the research arm of Baylor Health Care System, announced that it has formed a three-year partnership with Roche to jointly develop programs emerging from the human immunology platforms developed at the Baylor Institute for Immunology Research (BIIR), a component of BRI.
Bruker Corporation today announced that it has acquired Prairie Technologies, Inc. (Prairie), a provider of life science fluorescence microscopy products. The acquisition strengthens Bruker's position in life science markets, adding to the Bruker Nano Surfaces Division's existing life science atomic force microscopy (Bio-AFM) systems.
Synergy Pharmaceuticals, Inc., a developer of new drugs to treat gastrointestinal (GI) disorders and diseases, today announced initiation of dosing of patients in a major Phase II/III clinical trial of plecanatide to treat chronic idiopathic constipation.
MaxMuscleMass.com, an online body building supplement store, wants you to save up to 40% off the retail prices found in gyms and body building supplement retail stores.
› Verified 7 days ago
| Provider Name | Edward Y Chay |
|---|---|
| Provider Type | Practitioner - Ophthalmology |
| Provider Identifiers | NPI Number: 1851666143 PECOS PAC ID: 8325337876 Enrollment ID: I20170516000636 |
News Archive
The first indwelling endoluminal ureteral stent was described over 30 years ago and has since become a routine and indispensable urologic tool. However, the side effects and patient morbidity associated with ureteral stents are not insignificant.
Baylor Research Institute (BRI), the research arm of Baylor Health Care System, announced that it has formed a three-year partnership with Roche to jointly develop programs emerging from the human immunology platforms developed at the Baylor Institute for Immunology Research (BIIR), a component of BRI.
Bruker Corporation today announced that it has acquired Prairie Technologies, Inc. (Prairie), a provider of life science fluorescence microscopy products. The acquisition strengthens Bruker's position in life science markets, adding to the Bruker Nano Surfaces Division's existing life science atomic force microscopy (Bio-AFM) systems.
Synergy Pharmaceuticals, Inc., a developer of new drugs to treat gastrointestinal (GI) disorders and diseases, today announced initiation of dosing of patients in a major Phase II/III clinical trial of plecanatide to treat chronic idiopathic constipation.
MaxMuscleMass.com, an online body building supplement store, wants you to save up to 40% off the retail prices found in gyms and body building supplement retail stores.
› Verified 7 days ago
| Provider Name | Sundeep K. Kasi |
|---|---|
| Provider Type | Practitioner - Ophthalmology |
| Provider Identifiers | NPI Number: 1952697773 PECOS PAC ID: 0143541094 Enrollment ID: I20170630000467 |
News Archive
The first indwelling endoluminal ureteral stent was described over 30 years ago and has since become a routine and indispensable urologic tool. However, the side effects and patient morbidity associated with ureteral stents are not insignificant.
Baylor Research Institute (BRI), the research arm of Baylor Health Care System, announced that it has formed a three-year partnership with Roche to jointly develop programs emerging from the human immunology platforms developed at the Baylor Institute for Immunology Research (BIIR), a component of BRI.
Bruker Corporation today announced that it has acquired Prairie Technologies, Inc. (Prairie), a provider of life science fluorescence microscopy products. The acquisition strengthens Bruker's position in life science markets, adding to the Bruker Nano Surfaces Division's existing life science atomic force microscopy (Bio-AFM) systems.
Synergy Pharmaceuticals, Inc., a developer of new drugs to treat gastrointestinal (GI) disorders and diseases, today announced initiation of dosing of patients in a major Phase II/III clinical trial of plecanatide to treat chronic idiopathic constipation.
MaxMuscleMass.com, an online body building supplement store, wants you to save up to 40% off the retail prices found in gyms and body building supplement retail stores.
› Verified 7 days ago
| Provider Name | Brian K. Do |
|---|---|
| Provider Type | Practitioner - Ophthalmology |
| Provider Identifiers | NPI Number: 1073807681 PECOS PAC ID: 5092932632 Enrollment ID: I20180809000233 |
News Archive
The first indwelling endoluminal ureteral stent was described over 30 years ago and has since become a routine and indispensable urologic tool. However, the side effects and patient morbidity associated with ureteral stents are not insignificant.
Baylor Research Institute (BRI), the research arm of Baylor Health Care System, announced that it has formed a three-year partnership with Roche to jointly develop programs emerging from the human immunology platforms developed at the Baylor Institute for Immunology Research (BIIR), a component of BRI.
Bruker Corporation today announced that it has acquired Prairie Technologies, Inc. (Prairie), a provider of life science fluorescence microscopy products. The acquisition strengthens Bruker's position in life science markets, adding to the Bruker Nano Surfaces Division's existing life science atomic force microscopy (Bio-AFM) systems.
Synergy Pharmaceuticals, Inc., a developer of new drugs to treat gastrointestinal (GI) disorders and diseases, today announced initiation of dosing of patients in a major Phase II/III clinical trial of plecanatide to treat chronic idiopathic constipation.
MaxMuscleMass.com, an online body building supplement store, wants you to save up to 40% off the retail prices found in gyms and body building supplement retail stores.
› Verified 7 days ago
| Provider Name | Jacquelyn Weber |
|---|---|
| Provider Type | Practitioner - Ophthalmology |
| Provider Identifiers | NPI Number: 1689088155 PECOS PAC ID: 4284989286 Enrollment ID: I20190710001034 |
News Archive
The first indwelling endoluminal ureteral stent was described over 30 years ago and has since become a routine and indispensable urologic tool. However, the side effects and patient morbidity associated with ureteral stents are not insignificant.
Baylor Research Institute (BRI), the research arm of Baylor Health Care System, announced that it has formed a three-year partnership with Roche to jointly develop programs emerging from the human immunology platforms developed at the Baylor Institute for Immunology Research (BIIR), a component of BRI.
Bruker Corporation today announced that it has acquired Prairie Technologies, Inc. (Prairie), a provider of life science fluorescence microscopy products. The acquisition strengthens Bruker's position in life science markets, adding to the Bruker Nano Surfaces Division's existing life science atomic force microscopy (Bio-AFM) systems.
Synergy Pharmaceuticals, Inc., a developer of new drugs to treat gastrointestinal (GI) disorders and diseases, today announced initiation of dosing of patients in a major Phase II/III clinical trial of plecanatide to treat chronic idiopathic constipation.
MaxMuscleMass.com, an online body building supplement store, wants you to save up to 40% off the retail prices found in gyms and body building supplement retail stores.
› Verified 7 days ago
| Provider Name | Sneha Padidam |
|---|---|
| Provider Type | Practitioner - Ophthalmology |
| Provider Identifiers | NPI Number: 1356738942 PECOS PAC ID: 4082906664 Enrollment ID: I20190819001799 |
News Archive
The first indwelling endoluminal ureteral stent was described over 30 years ago and has since become a routine and indispensable urologic tool. However, the side effects and patient morbidity associated with ureteral stents are not insignificant.
Baylor Research Institute (BRI), the research arm of Baylor Health Care System, announced that it has formed a three-year partnership with Roche to jointly develop programs emerging from the human immunology platforms developed at the Baylor Institute for Immunology Research (BIIR), a component of BRI.
Bruker Corporation today announced that it has acquired Prairie Technologies, Inc. (Prairie), a provider of life science fluorescence microscopy products. The acquisition strengthens Bruker's position in life science markets, adding to the Bruker Nano Surfaces Division's existing life science atomic force microscopy (Bio-AFM) systems.
Synergy Pharmaceuticals, Inc., a developer of new drugs to treat gastrointestinal (GI) disorders and diseases, today announced initiation of dosing of patients in a major Phase II/III clinical trial of plecanatide to treat chronic idiopathic constipation.
MaxMuscleMass.com, an online body building supplement store, wants you to save up to 40% off the retail prices found in gyms and body building supplement retail stores.
› Verified 7 days ago
| Provider Name | Mohsin Hasan Ali |
|---|---|
| Provider Type | Practitioner - Ophthalmology |
| Provider Identifiers | NPI Number: 1063855534 PECOS PAC ID: 5395055479 Enrollment ID: I20190924002926 |
News Archive
The first indwelling endoluminal ureteral stent was described over 30 years ago and has since become a routine and indispensable urologic tool. However, the side effects and patient morbidity associated with ureteral stents are not insignificant.
Baylor Research Institute (BRI), the research arm of Baylor Health Care System, announced that it has formed a three-year partnership with Roche to jointly develop programs emerging from the human immunology platforms developed at the Baylor Institute for Immunology Research (BIIR), a component of BRI.
Bruker Corporation today announced that it has acquired Prairie Technologies, Inc. (Prairie), a provider of life science fluorescence microscopy products. The acquisition strengthens Bruker's position in life science markets, adding to the Bruker Nano Surfaces Division's existing life science atomic force microscopy (Bio-AFM) systems.
Synergy Pharmaceuticals, Inc., a developer of new drugs to treat gastrointestinal (GI) disorders and diseases, today announced initiation of dosing of patients in a major Phase II/III clinical trial of plecanatide to treat chronic idiopathic constipation.
MaxMuscleMass.com, an online body building supplement store, wants you to save up to 40% off the retail prices found in gyms and body building supplement retail stores.
› Verified 7 days ago
| Provider Name | Jason Mingyi Huang |
|---|---|
| Provider Type | Practitioner - Ophthalmology |
| Provider Identifiers | NPI Number: 1093058059 PECOS PAC ID: 3173892650 Enrollment ID: I20190924003494 |
News Archive
The first indwelling endoluminal ureteral stent was described over 30 years ago and has since become a routine and indispensable urologic tool. However, the side effects and patient morbidity associated with ureteral stents are not insignificant.
Baylor Research Institute (BRI), the research arm of Baylor Health Care System, announced that it has formed a three-year partnership with Roche to jointly develop programs emerging from the human immunology platforms developed at the Baylor Institute for Immunology Research (BIIR), a component of BRI.
Bruker Corporation today announced that it has acquired Prairie Technologies, Inc. (Prairie), a provider of life science fluorescence microscopy products. The acquisition strengthens Bruker's position in life science markets, adding to the Bruker Nano Surfaces Division's existing life science atomic force microscopy (Bio-AFM) systems.
Synergy Pharmaceuticals, Inc., a developer of new drugs to treat gastrointestinal (GI) disorders and diseases, today announced initiation of dosing of patients in a major Phase II/III clinical trial of plecanatide to treat chronic idiopathic constipation.
MaxMuscleMass.com, an online body building supplement store, wants you to save up to 40% off the retail prices found in gyms and body building supplement retail stores.
› Verified 7 days ago
| Provider Name | Anahita Abazari |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1477048452 PECOS PAC ID: 1355672742 Enrollment ID: I20191016002410 |
News Archive
The first indwelling endoluminal ureteral stent was described over 30 years ago and has since become a routine and indispensable urologic tool. However, the side effects and patient morbidity associated with ureteral stents are not insignificant.
Baylor Research Institute (BRI), the research arm of Baylor Health Care System, announced that it has formed a three-year partnership with Roche to jointly develop programs emerging from the human immunology platforms developed at the Baylor Institute for Immunology Research (BIIR), a component of BRI.
Bruker Corporation today announced that it has acquired Prairie Technologies, Inc. (Prairie), a provider of life science fluorescence microscopy products. The acquisition strengthens Bruker's position in life science markets, adding to the Bruker Nano Surfaces Division's existing life science atomic force microscopy (Bio-AFM) systems.
Synergy Pharmaceuticals, Inc., a developer of new drugs to treat gastrointestinal (GI) disorders and diseases, today announced initiation of dosing of patients in a major Phase II/III clinical trial of plecanatide to treat chronic idiopathic constipation.
MaxMuscleMass.com, an online body building supplement store, wants you to save up to 40% off the retail prices found in gyms and body building supplement retail stores.
› Verified 7 days ago
| Provider Name | Kenny Chen |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1861902959 PECOS PAC ID: 7911330436 Enrollment ID: I20191217000116 |
News Archive
The first indwelling endoluminal ureteral stent was described over 30 years ago and has since become a routine and indispensable urologic tool. However, the side effects and patient morbidity associated with ureteral stents are not insignificant.
Baylor Research Institute (BRI), the research arm of Baylor Health Care System, announced that it has formed a three-year partnership with Roche to jointly develop programs emerging from the human immunology platforms developed at the Baylor Institute for Immunology Research (BIIR), a component of BRI.
Bruker Corporation today announced that it has acquired Prairie Technologies, Inc. (Prairie), a provider of life science fluorescence microscopy products. The acquisition strengthens Bruker's position in life science markets, adding to the Bruker Nano Surfaces Division's existing life science atomic force microscopy (Bio-AFM) systems.
Synergy Pharmaceuticals, Inc., a developer of new drugs to treat gastrointestinal (GI) disorders and diseases, today announced initiation of dosing of patients in a major Phase II/III clinical trial of plecanatide to treat chronic idiopathic constipation.
MaxMuscleMass.com, an online body building supplement store, wants you to save up to 40% off the retail prices found in gyms and body building supplement retail stores.
› Verified 7 days ago
| Provider Name | Mariam Mathai |
|---|---|
| Provider Type | Practitioner - Ophthalmology |
| Provider Identifiers | NPI Number: 1346694668 PECOS PAC ID: 7416378211 Enrollment ID: I20200603001913 |
News Archive
The first indwelling endoluminal ureteral stent was described over 30 years ago and has since become a routine and indispensable urologic tool. However, the side effects and patient morbidity associated with ureteral stents are not insignificant.
Baylor Research Institute (BRI), the research arm of Baylor Health Care System, announced that it has formed a three-year partnership with Roche to jointly develop programs emerging from the human immunology platforms developed at the Baylor Institute for Immunology Research (BIIR), a component of BRI.
Bruker Corporation today announced that it has acquired Prairie Technologies, Inc. (Prairie), a provider of life science fluorescence microscopy products. The acquisition strengthens Bruker's position in life science markets, adding to the Bruker Nano Surfaces Division's existing life science atomic force microscopy (Bio-AFM) systems.
Synergy Pharmaceuticals, Inc., a developer of new drugs to treat gastrointestinal (GI) disorders and diseases, today announced initiation of dosing of patients in a major Phase II/III clinical trial of plecanatide to treat chronic idiopathic constipation.
MaxMuscleMass.com, an online body building supplement store, wants you to save up to 40% off the retail prices found in gyms and body building supplement retail stores.
› Verified 7 days ago
| Provider Name | Arthi Venkat |
|---|---|
| Provider Type | Practitioner - Ophthalmology |
| Provider Identifiers | NPI Number: 1013274919 PECOS PAC ID: 9032403811 Enrollment ID: I20200827001796 |
News Archive
The first indwelling endoluminal ureteral stent was described over 30 years ago and has since become a routine and indispensable urologic tool. However, the side effects and patient morbidity associated with ureteral stents are not insignificant.
Baylor Research Institute (BRI), the research arm of Baylor Health Care System, announced that it has formed a three-year partnership with Roche to jointly develop programs emerging from the human immunology platforms developed at the Baylor Institute for Immunology Research (BIIR), a component of BRI.
Bruker Corporation today announced that it has acquired Prairie Technologies, Inc. (Prairie), a provider of life science fluorescence microscopy products. The acquisition strengthens Bruker's position in life science markets, adding to the Bruker Nano Surfaces Division's existing life science atomic force microscopy (Bio-AFM) systems.
Synergy Pharmaceuticals, Inc., a developer of new drugs to treat gastrointestinal (GI) disorders and diseases, today announced initiation of dosing of patients in a major Phase II/III clinical trial of plecanatide to treat chronic idiopathic constipation.
MaxMuscleMass.com, an online body building supplement store, wants you to save up to 40% off the retail prices found in gyms and body building supplement retail stores.
› Verified 7 days ago
| Provider Name | Bradley H Jacobsen |
|---|---|
| Provider Type | Practitioner - Ophthalmology |
| Provider Identifiers | NPI Number: 1760845184 PECOS PAC ID: 9537425053 Enrollment ID: I20210614000407 |
News Archive
The first indwelling endoluminal ureteral stent was described over 30 years ago and has since become a routine and indispensable urologic tool. However, the side effects and patient morbidity associated with ureteral stents are not insignificant.
Baylor Research Institute (BRI), the research arm of Baylor Health Care System, announced that it has formed a three-year partnership with Roche to jointly develop programs emerging from the human immunology platforms developed at the Baylor Institute for Immunology Research (BIIR), a component of BRI.
Bruker Corporation today announced that it has acquired Prairie Technologies, Inc. (Prairie), a provider of life science fluorescence microscopy products. The acquisition strengthens Bruker's position in life science markets, adding to the Bruker Nano Surfaces Division's existing life science atomic force microscopy (Bio-AFM) systems.
Synergy Pharmaceuticals, Inc., a developer of new drugs to treat gastrointestinal (GI) disorders and diseases, today announced initiation of dosing of patients in a major Phase II/III clinical trial of plecanatide to treat chronic idiopathic constipation.
MaxMuscleMass.com, an online body building supplement store, wants you to save up to 40% off the retail prices found in gyms and body building supplement retail stores.
› Verified 7 days ago
| Provider Name | Travis Peck |
|---|---|
| Provider Type | Practitioner - Ophthalmology |
| Provider Identifiers | NPI Number: 1982132502 PECOS PAC ID: 2062781073 Enrollment ID: I20210709001829 |
News Archive
The first indwelling endoluminal ureteral stent was described over 30 years ago and has since become a routine and indispensable urologic tool. However, the side effects and patient morbidity associated with ureteral stents are not insignificant.
Baylor Research Institute (BRI), the research arm of Baylor Health Care System, announced that it has formed a three-year partnership with Roche to jointly develop programs emerging from the human immunology platforms developed at the Baylor Institute for Immunology Research (BIIR), a component of BRI.
Bruker Corporation today announced that it has acquired Prairie Technologies, Inc. (Prairie), a provider of life science fluorescence microscopy products. The acquisition strengthens Bruker's position in life science markets, adding to the Bruker Nano Surfaces Division's existing life science atomic force microscopy (Bio-AFM) systems.
Synergy Pharmaceuticals, Inc., a developer of new drugs to treat gastrointestinal (GI) disorders and diseases, today announced initiation of dosing of patients in a major Phase II/III clinical trial of plecanatide to treat chronic idiopathic constipation.
MaxMuscleMass.com, an online body building supplement store, wants you to save up to 40% off the retail prices found in gyms and body building supplement retail stores.
› Verified 7 days ago
| Provider Name | Claudia Gomez Hooten |
|---|---|
| Provider Type | Practitioner - Ophthalmology |
| Provider Identifiers | NPI Number: 1629360458 PECOS PAC ID: 7315252640 Enrollment ID: I20210804000564 |
News Archive
The first indwelling endoluminal ureteral stent was described over 30 years ago and has since become a routine and indispensable urologic tool. However, the side effects and patient morbidity associated with ureteral stents are not insignificant.
Baylor Research Institute (BRI), the research arm of Baylor Health Care System, announced that it has formed a three-year partnership with Roche to jointly develop programs emerging from the human immunology platforms developed at the Baylor Institute for Immunology Research (BIIR), a component of BRI.
Bruker Corporation today announced that it has acquired Prairie Technologies, Inc. (Prairie), a provider of life science fluorescence microscopy products. The acquisition strengthens Bruker's position in life science markets, adding to the Bruker Nano Surfaces Division's existing life science atomic force microscopy (Bio-AFM) systems.
Synergy Pharmaceuticals, Inc., a developer of new drugs to treat gastrointestinal (GI) disorders and diseases, today announced initiation of dosing of patients in a major Phase II/III clinical trial of plecanatide to treat chronic idiopathic constipation.
MaxMuscleMass.com, an online body building supplement store, wants you to save up to 40% off the retail prices found in gyms and body building supplement retail stores.
› Verified 7 days ago
| Provider Name | Tan Xu |
|---|---|
| Provider Type | Practitioner - Ophthalmology |
| Provider Identifiers | NPI Number: 1831586072 PECOS PAC ID: 6103126388 Enrollment ID: I20211208002401 |
News Archive
The first indwelling endoluminal ureteral stent was described over 30 years ago and has since become a routine and indispensable urologic tool. However, the side effects and patient morbidity associated with ureteral stents are not insignificant.
Baylor Research Institute (BRI), the research arm of Baylor Health Care System, announced that it has formed a three-year partnership with Roche to jointly develop programs emerging from the human immunology platforms developed at the Baylor Institute for Immunology Research (BIIR), a component of BRI.
Bruker Corporation today announced that it has acquired Prairie Technologies, Inc. (Prairie), a provider of life science fluorescence microscopy products. The acquisition strengthens Bruker's position in life science markets, adding to the Bruker Nano Surfaces Division's existing life science atomic force microscopy (Bio-AFM) systems.
Synergy Pharmaceuticals, Inc., a developer of new drugs to treat gastrointestinal (GI) disorders and diseases, today announced initiation of dosing of patients in a major Phase II/III clinical trial of plecanatide to treat chronic idiopathic constipation.
MaxMuscleMass.com, an online body building supplement store, wants you to save up to 40% off the retail prices found in gyms and body building supplement retail stores.
› Verified 7 days ago
| Provider Name | Rachel Chen |
|---|---|
| Provider Type | Practitioner - Ophthalmology |
| Provider Identifiers | NPI Number: 1558740605 PECOS PAC ID: 7618261223 Enrollment ID: I20211215002366 |
News Archive
The first indwelling endoluminal ureteral stent was described over 30 years ago and has since become a routine and indispensable urologic tool. However, the side effects and patient morbidity associated with ureteral stents are not insignificant.
Baylor Research Institute (BRI), the research arm of Baylor Health Care System, announced that it has formed a three-year partnership with Roche to jointly develop programs emerging from the human immunology platforms developed at the Baylor Institute for Immunology Research (BIIR), a component of BRI.
Bruker Corporation today announced that it has acquired Prairie Technologies, Inc. (Prairie), a provider of life science fluorescence microscopy products. The acquisition strengthens Bruker's position in life science markets, adding to the Bruker Nano Surfaces Division's existing life science atomic force microscopy (Bio-AFM) systems.
Synergy Pharmaceuticals, Inc., a developer of new drugs to treat gastrointestinal (GI) disorders and diseases, today announced initiation of dosing of patients in a major Phase II/III clinical trial of plecanatide to treat chronic idiopathic constipation.
MaxMuscleMass.com, an online body building supplement store, wants you to save up to 40% off the retail prices found in gyms and body building supplement retail stores.
› Verified 7 days ago
| Provider Name | Osama Sabbagh |
|---|---|
| Provider Type | Practitioner - Ophthalmology |
| Provider Identifiers | NPI Number: 1548647928 PECOS PAC ID: 5597098459 Enrollment ID: I20220401002350 |
News Archive
The first indwelling endoluminal ureteral stent was described over 30 years ago and has since become a routine and indispensable urologic tool. However, the side effects and patient morbidity associated with ureteral stents are not insignificant.
Baylor Research Institute (BRI), the research arm of Baylor Health Care System, announced that it has formed a three-year partnership with Roche to jointly develop programs emerging from the human immunology platforms developed at the Baylor Institute for Immunology Research (BIIR), a component of BRI.
Bruker Corporation today announced that it has acquired Prairie Technologies, Inc. (Prairie), a provider of life science fluorescence microscopy products. The acquisition strengthens Bruker's position in life science markets, adding to the Bruker Nano Surfaces Division's existing life science atomic force microscopy (Bio-AFM) systems.
Synergy Pharmaceuticals, Inc., a developer of new drugs to treat gastrointestinal (GI) disorders and diseases, today announced initiation of dosing of patients in a major Phase II/III clinical trial of plecanatide to treat chronic idiopathic constipation.
MaxMuscleMass.com, an online body building supplement store, wants you to save up to 40% off the retail prices found in gyms and body building supplement retail stores.
› Verified 7 days ago
| Provider Name | Aditya Rali |
|---|---|
| Provider Type | Practitioner - Ophthalmology |
| Provider Identifiers | NPI Number: 1972009827 PECOS PAC ID: 4082964663 Enrollment ID: I20220707000222 |
News Archive
The first indwelling endoluminal ureteral stent was described over 30 years ago and has since become a routine and indispensable urologic tool. However, the side effects and patient morbidity associated with ureteral stents are not insignificant.
Baylor Research Institute (BRI), the research arm of Baylor Health Care System, announced that it has formed a three-year partnership with Roche to jointly develop programs emerging from the human immunology platforms developed at the Baylor Institute for Immunology Research (BIIR), a component of BRI.
Bruker Corporation today announced that it has acquired Prairie Technologies, Inc. (Prairie), a provider of life science fluorescence microscopy products. The acquisition strengthens Bruker's position in life science markets, adding to the Bruker Nano Surfaces Division's existing life science atomic force microscopy (Bio-AFM) systems.
Synergy Pharmaceuticals, Inc., a developer of new drugs to treat gastrointestinal (GI) disorders and diseases, today announced initiation of dosing of patients in a major Phase II/III clinical trial of plecanatide to treat chronic idiopathic constipation.
MaxMuscleMass.com, an online body building supplement store, wants you to save up to 40% off the retail prices found in gyms and body building supplement retail stores.
› Verified 7 days ago
| Provider Name | Janani Singaravelu |
|---|---|
| Provider Type | Practitioner - Ophthalmology |
| Provider Identifiers | NPI Number: 1972037521 PECOS PAC ID: 7911277108 Enrollment ID: I20220711001256 |
News Archive
The first indwelling endoluminal ureteral stent was described over 30 years ago and has since become a routine and indispensable urologic tool. However, the side effects and patient morbidity associated with ureteral stents are not insignificant.
Baylor Research Institute (BRI), the research arm of Baylor Health Care System, announced that it has formed a three-year partnership with Roche to jointly develop programs emerging from the human immunology platforms developed at the Baylor Institute for Immunology Research (BIIR), a component of BRI.
Bruker Corporation today announced that it has acquired Prairie Technologies, Inc. (Prairie), a provider of life science fluorescence microscopy products. The acquisition strengthens Bruker's position in life science markets, adding to the Bruker Nano Surfaces Division's existing life science atomic force microscopy (Bio-AFM) systems.
Synergy Pharmaceuticals, Inc., a developer of new drugs to treat gastrointestinal (GI) disorders and diseases, today announced initiation of dosing of patients in a major Phase II/III clinical trial of plecanatide to treat chronic idiopathic constipation.
MaxMuscleMass.com, an online body building supplement store, wants you to save up to 40% off the retail prices found in gyms and body building supplement retail stores.
› Verified 7 days ago
| Provider Name | Jeanette Du |
|---|---|
| Provider Type | Practitioner - Ophthalmology |
| Provider Identifiers | NPI Number: 1760941538 PECOS PAC ID: 9931430147 Enrollment ID: I20230718000564 |
News Archive
The first indwelling endoluminal ureteral stent was described over 30 years ago and has since become a routine and indispensable urologic tool. However, the side effects and patient morbidity associated with ureteral stents are not insignificant.
Baylor Research Institute (BRI), the research arm of Baylor Health Care System, announced that it has formed a three-year partnership with Roche to jointly develop programs emerging from the human immunology platforms developed at the Baylor Institute for Immunology Research (BIIR), a component of BRI.
Bruker Corporation today announced that it has acquired Prairie Technologies, Inc. (Prairie), a provider of life science fluorescence microscopy products. The acquisition strengthens Bruker's position in life science markets, adding to the Bruker Nano Surfaces Division's existing life science atomic force microscopy (Bio-AFM) systems.
Synergy Pharmaceuticals, Inc., a developer of new drugs to treat gastrointestinal (GI) disorders and diseases, today announced initiation of dosing of patients in a major Phase II/III clinical trial of plecanatide to treat chronic idiopathic constipation.
MaxMuscleMass.com, an online body building supplement store, wants you to save up to 40% off the retail prices found in gyms and body building supplement retail stores.
› Verified 7 days ago
| Provider Name | Daniel W Wang |
|---|---|
| Provider Type | Practitioner - Ophthalmology |
| Provider Identifiers | NPI Number: 1871024414 PECOS PAC ID: 3678842218 Enrollment ID: I20230901000932 |
News Archive
The first indwelling endoluminal ureteral stent was described over 30 years ago and has since become a routine and indispensable urologic tool. However, the side effects and patient morbidity associated with ureteral stents are not insignificant.
Baylor Research Institute (BRI), the research arm of Baylor Health Care System, announced that it has formed a three-year partnership with Roche to jointly develop programs emerging from the human immunology platforms developed at the Baylor Institute for Immunology Research (BIIR), a component of BRI.
Bruker Corporation today announced that it has acquired Prairie Technologies, Inc. (Prairie), a provider of life science fluorescence microscopy products. The acquisition strengthens Bruker's position in life science markets, adding to the Bruker Nano Surfaces Division's existing life science atomic force microscopy (Bio-AFM) systems.
Synergy Pharmaceuticals, Inc., a developer of new drugs to treat gastrointestinal (GI) disorders and diseases, today announced initiation of dosing of patients in a major Phase II/III clinical trial of plecanatide to treat chronic idiopathic constipation.
MaxMuscleMass.com, an online body building supplement store, wants you to save up to 40% off the retail prices found in gyms and body building supplement retail stores.
› Verified 7 days ago
| Provider Name | Jared Ebert |
|---|---|
| Provider Type | Practitioner - Ophthalmology |
| Provider Identifiers | NPI Number: 1790244572 PECOS PAC ID: 8628305802 Enrollment ID: I20230911001022 |
News Archive
The first indwelling endoluminal ureteral stent was described over 30 years ago and has since become a routine and indispensable urologic tool. However, the side effects and patient morbidity associated with ureteral stents are not insignificant.
Baylor Research Institute (BRI), the research arm of Baylor Health Care System, announced that it has formed a three-year partnership with Roche to jointly develop programs emerging from the human immunology platforms developed at the Baylor Institute for Immunology Research (BIIR), a component of BRI.
Bruker Corporation today announced that it has acquired Prairie Technologies, Inc. (Prairie), a provider of life science fluorescence microscopy products. The acquisition strengthens Bruker's position in life science markets, adding to the Bruker Nano Surfaces Division's existing life science atomic force microscopy (Bio-AFM) systems.
Synergy Pharmaceuticals, Inc., a developer of new drugs to treat gastrointestinal (GI) disorders and diseases, today announced initiation of dosing of patients in a major Phase II/III clinical trial of plecanatide to treat chronic idiopathic constipation.
MaxMuscleMass.com, an online body building supplement store, wants you to save up to 40% off the retail prices found in gyms and body building supplement retail stores.
› Verified 7 days ago
| Provider Name | Ethan Sobol |
|---|---|
| Provider Type | Practitioner - Ophthalmology |
| Provider Identifiers | NPI Number: 1922530336 PECOS PAC ID: 6901142843 Enrollment ID: I20230921004100 |
News Archive
The first indwelling endoluminal ureteral stent was described over 30 years ago and has since become a routine and indispensable urologic tool. However, the side effects and patient morbidity associated with ureteral stents are not insignificant.
Baylor Research Institute (BRI), the research arm of Baylor Health Care System, announced that it has formed a three-year partnership with Roche to jointly develop programs emerging from the human immunology platforms developed at the Baylor Institute for Immunology Research (BIIR), a component of BRI.
Bruker Corporation today announced that it has acquired Prairie Technologies, Inc. (Prairie), a provider of life science fluorescence microscopy products. The acquisition strengthens Bruker's position in life science markets, adding to the Bruker Nano Surfaces Division's existing life science atomic force microscopy (Bio-AFM) systems.
Synergy Pharmaceuticals, Inc., a developer of new drugs to treat gastrointestinal (GI) disorders and diseases, today announced initiation of dosing of patients in a major Phase II/III clinical trial of plecanatide to treat chronic idiopathic constipation.
MaxMuscleMass.com, an online body building supplement store, wants you to save up to 40% off the retail prices found in gyms and body building supplement retail stores.
› Verified 7 days ago
| Provider Name | Rachel Mogil |
|---|---|
| Provider Type | Practitioner - Ophthalmology |
| Provider Identifiers | NPI Number: 1437682606 PECOS PAC ID: 0244501278 Enrollment ID: I20230922002271 |
News Archive
The first indwelling endoluminal ureteral stent was described over 30 years ago and has since become a routine and indispensable urologic tool. However, the side effects and patient morbidity associated with ureteral stents are not insignificant.
Baylor Research Institute (BRI), the research arm of Baylor Health Care System, announced that it has formed a three-year partnership with Roche to jointly develop programs emerging from the human immunology platforms developed at the Baylor Institute for Immunology Research (BIIR), a component of BRI.
Bruker Corporation today announced that it has acquired Prairie Technologies, Inc. (Prairie), a provider of life science fluorescence microscopy products. The acquisition strengthens Bruker's position in life science markets, adding to the Bruker Nano Surfaces Division's existing life science atomic force microscopy (Bio-AFM) systems.
Synergy Pharmaceuticals, Inc., a developer of new drugs to treat gastrointestinal (GI) disorders and diseases, today announced initiation of dosing of patients in a major Phase II/III clinical trial of plecanatide to treat chronic idiopathic constipation.
MaxMuscleMass.com, an online body building supplement store, wants you to save up to 40% off the retail prices found in gyms and body building supplement retail stores.
› Verified 7 days ago
| Provider Name | James Bavinger |
|---|---|
| Provider Type | Practitioner - Ophthalmology |
| Provider Identifiers | NPI Number: 1760936819 PECOS PAC ID: 3779863949 Enrollment ID: I20231017000014 |
News Archive
The first indwelling endoluminal ureteral stent was described over 30 years ago and has since become a routine and indispensable urologic tool. However, the side effects and patient morbidity associated with ureteral stents are not insignificant.
Baylor Research Institute (BRI), the research arm of Baylor Health Care System, announced that it has formed a three-year partnership with Roche to jointly develop programs emerging from the human immunology platforms developed at the Baylor Institute for Immunology Research (BIIR), a component of BRI.
Bruker Corporation today announced that it has acquired Prairie Technologies, Inc. (Prairie), a provider of life science fluorescence microscopy products. The acquisition strengthens Bruker's position in life science markets, adding to the Bruker Nano Surfaces Division's existing life science atomic force microscopy (Bio-AFM) systems.
Synergy Pharmaceuticals, Inc., a developer of new drugs to treat gastrointestinal (GI) disorders and diseases, today announced initiation of dosing of patients in a major Phase II/III clinical trial of plecanatide to treat chronic idiopathic constipation.
MaxMuscleMass.com, an online body building supplement store, wants you to save up to 40% off the retail prices found in gyms and body building supplement retail stores.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| The Retina Group Of Washington, Pllc 420 Mountain Ave Fl 4, New Providence, NJ 07974-2736 Ph: () - | The Retina Group Of Washington, Pllc 7501greenway Center Dr, # 300, Greenbelt, MD 20770-3502 Ph: (301) 474-4679 |
News Archive
The first indwelling endoluminal ureteral stent was described over 30 years ago and has since become a routine and indispensable urologic tool. However, the side effects and patient morbidity associated with ureteral stents are not insignificant.
Baylor Research Institute (BRI), the research arm of Baylor Health Care System, announced that it has formed a three-year partnership with Roche to jointly develop programs emerging from the human immunology platforms developed at the Baylor Institute for Immunology Research (BIIR), a component of BRI.
Bruker Corporation today announced that it has acquired Prairie Technologies, Inc. (Prairie), a provider of life science fluorescence microscopy products. The acquisition strengthens Bruker's position in life science markets, adding to the Bruker Nano Surfaces Division's existing life science atomic force microscopy (Bio-AFM) systems.
Synergy Pharmaceuticals, Inc., a developer of new drugs to treat gastrointestinal (GI) disorders and diseases, today announced initiation of dosing of patients in a major Phase II/III clinical trial of plecanatide to treat chronic idiopathic constipation.
MaxMuscleMass.com, an online body building supplement store, wants you to save up to 40% off the retail prices found in gyms and body building supplement retail stores.
› Verified 7 days ago